im back in this one. private equity in the shadows, 188 mil cash in bank - minus 25mil cash for merger with EGX will leave 69c of CASH post merger (ie 235 mil shares).
so 163mil AUD is what i paid (at 1.39) for:
1. PTDs animal business - PTD is aiming to divest this - not worth much imho
2. Profitable TNF businesss - royalties for nx 5 years
3. PTDs unproven products (high risk, value uncertain)
4. EGXs patents (high risk, value uncertain)
even though 3 & 4 are intangibles, the fact that domantis was sold for so much for its POTENTIAL VALUE suggests that 3+4 is worth imho at least 163 mil AUD. i will double up my holdings in PTD if it goes down to 1 - 1.2.
- Forums
- ASX - By Stock
- buy
PTD
unknown
im back in this one. private equity in the shadows, 188 mil cash...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online